MARATTO

article · Nuclear Medicine Review

Optic nerve sheath meningioma detected by somatostatin receptor scintigraphy with [99mTc]Tc-Tektrotyd

2024Open accessMohammed V University

Abstract

Optic nerve sheath meningiomas are rare and difficult to diagnose accurately due to the high risk of visual loss associated with histologic confirmation. Currently, the primary imaging techniques used for diagnosis are contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI). However, these methods may not always provide a definitive diagnosis, necessitating alternative approaches. This case study is one of the few that reports the use of a [99mTc]Tc-Tektrotyd single-photon emission computed tomography (SPECT/CT) scan for the non-invasive diagnosis of an orbital space-occupying tumor. This radiopharmaceutical can bind with high affinity to somatostatin receptor subtype 2, which is expressed in meningiomas.

Research topics

  • Meningioma and schwannoma management
  • Neurofibromatosis and Schwannoma Cases
  • Adrenal and Paraganglionic Tumors

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.5603/nmr.102384

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.